Please be aware that this is a machine translation from French to English. AVICENN is not responsible for incorrect or inaccurate translations but welcomes suggestions for reformulation.

VeilleNanos - MBBT or "Bisoctrizole" in nano form

MBBT or “Bisoctrizole” in nano form

image
News
+ Info sheets
Agenda

By the AVICENN team – Last updated November 2020

Nano MBBT

Methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), otherwise known as “Bisoctrizole” (CAS number: 103597-45-1), is a UV filter authorized in nano form at the European level within the framework of the Cosmetics Regulation at a concentration of 10 % m/m (except for applications that may result in end-user lung exposure through inhalation of this substance). It is used in the BASF product Tinosorb®1MCf. BASF welcomes EU approval of nano-sized UV filter in cosmetics, BASF, July 30, 2018.

According to the Ministry of Ecological Transition and Solidarity2Cf. bilan R-nano 2019, Ministry of Ecological Transition and Solidarity, June 2020, between 10 and 100 tons of nano MBBT were officially imported or manufactured in France in 2018. This range is not very precise and should be considered as an indication only because the quantities registered in the French R-nano register are below the quantities actually present on the French market, as many nanomaterials escape declaration.

There are strong uncertainties about the risks associated with MBBT, which is insoluble and persistent/bioaccumulative, leading the European Scientific Committee on Consumer Safety (SCCS) to place nano MBBT at the top of the list of riskiest nanomaterials in the cosmetics sector in October 2020.

Any questions or comments? This information sheet compiled by AVICENN is intended to be completed and updated. Please feel free to contribute.

Upcoming Nano Agenda

5
Oct.
2025
NaMasTE thematic school (CNRS, Ile d’Oléron – France)
Ile d'Oléron
Training
  • Thematic school of the NaMasTE research group (Manufactured Nanomaterials, Toxicology, Ecotoxicology and Risks: towards controlled development)
  • Public: engineers, researchers (contract and permanent), PhD students, industrialists and members of associations working on nanomaterials.
  • The program includes the physical chemistry, biology and environmental sciences needed to understand the key aspects involved in the controlled development of nanomaterials.
    → Safer-by-design approaches, which integrate analysis of the production, characterization of properties, fate, and impacts (beneficial or harmful) of nanomaterials and products containing them throughout their life cycle
  • Dates: October 5 to 10, 2025
  • Organizers: CNRS
  • Website: https://namaste.sciencesconf.org
6
Oct.
2025
Characterizing and preventing risks related to manufactured nanomaterials and ultrafine particles (INRS, Vandœuvre-Lès-Nancy – France)
Nancy
Training
  • Training intended for occupational physicians, occupational risk prevention specialists (IPRP), company prevention specialists, prevention department staff from Carsat, Cramif and CGSS, institutional prevention specialists (Dreets, Dreal, MSA…).
  • Organizer: French National institute of research and security (INRS)
  • October 6 to 10, 2025
  • Website: www.inrs.fr/…/formation/…JA1030_2025
6
Oct.
2025
Scientific integrity, manipulation of scientific information, industry influence strategies and whistleblower protection (Université Paris Cité, Paris – France)
Paris
Conference
health
conflicts of interest
health
information
research
risks
science and society
  • 3pm – Conference by Irène Frachon on her fight to reveal the dangers of Mediator, the difficulties encountered by whistleblowers in the face of institutional and industrial pressure, and the importance of their role in defending public health.
  • 4pm – Round table on the manipulation of scientific information and the defense of whistleblowers moderated by Raphaël Lévy (professor of physics at Sorbonne Paris Nord University, specialist in nanoparticles and their uses in biology, coordinator of the ERC NanoBubbles project dedicated to research into the corrective mechanisms of science), with :
    • Maud Bernisson, post-doctoral fellow at LISIS (CNRS), member of the ERC NanoBubbles project, on the mechanisms of influence of pharmaceutical companies in the scientific field.
    • Marc Samama, professor, anesthesiologist, co-chairman of the Commission des blocs et plateaux techniques de la CME de l’AP-HP, past Editor-in-Chief of the European Journal of Anaesthesiology, director of the Office de l’Intégrité Scientifique de l’AP-HP.
    • Solène Lellinger, Senior Lecturer in the History and Philosophy of Health at Paris Cité University, specializing in the socio-history of medicines and their intersection with medical practices, and in particular the ways in which knowledge and information about medicines are produced.
    • Cécile Barrois de Sarigny, Deputy Ombudsman in charge of whistleblower protection.
  • With the support of the ERC Synergy NanoBubbles project
  • Website: https://u-paris.fr/sante/irene-frachon-a-paris-une-conference-et-une-table-ronde-sur-lintegrite-scientifique

File initially created in November 2020


Notes and references

Our monitoring, information and actions need you to continue !